SEMA3A and glioblastoma: Moreover, recombinant Sema3A was found to repel rat C6 GBM cell migration; however, upon blockade of its receptor complex formed by NRP1/Plexin-A1 this activity was unexpectedly switched to NRP2-dependent chemoattraction [27].